213 related articles for article (PubMed ID: 2243354)
1. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid.
Beauchamp D; Laurent G; Maldague P; Abid S; Kishore BK; Tulkens PM
J Pharmacol Exp Ther; 1990 Nov; 255(2):858-66. PubMed ID: 2243354
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
Kishore BK; Kállay Z; Lambricht P; Laurent G; Tulkens PM
J Pharmacol Exp Ther; 1990 Nov; 255(2):867-74. PubMed ID: 2243355
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids.
Kishore BK; Lambricht P; Laurent G; Maldague P; Wagner R; Tulkens PM
J Pharmacol Exp Ther; 1990 Nov; 255(2):875-85. PubMed ID: 1700819
[TBL] [Abstract][Full Text] [Related]
4. Comparative assessment of poly-L-aspartic and poly-L-glutamic acids as protectants against gentamicin-induced renal lysosomal phospholipidosis, phospholipiduria and cell proliferation in rats.
Kishore BK; Ibrahim S; Lambricht P; Laurent G; Maldague P; Tulkens PM
J Pharmacol Exp Ther; 1992 Jul; 262(1):424-32. PubMed ID: 1378098
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of gentamicin nephrotoxicity in the rat by infusion of aprotinin.
Morin NJ; Frau A; Nonclercq D; Toubeau G; Zanen J; Heuson-Stiennon JA; Bergeron MG; Beauchamp D; Laurent G
Exp Mol Pathol; 1994 Jun; 60(3):197-213. PubMed ID: 7525340
[TBL] [Abstract][Full Text] [Related]
6. Polyaspartic acid protects against gentamicin nephrotoxicity in the rat.
Ramsammy LS; Josepovitz C; Lane BP; Kaloyanides GJ
J Pharmacol Exp Ther; 1989 Jul; 250(1):149-53. PubMed ID: 2746494
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of renal membrane binding and nephrotoxicity of gentamicin by polyasparagine and polyaspartic acid in the rat.
Williams PD; Hottendorf GH
Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):317-20. PubMed ID: 3838817
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent gentamicin experimental nephrotoxicity.
Beauchamp D; Gourde P; Thériault G; Bergeron MG
J Pharmacol Exp Ther; 1992 Feb; 260(2):444-9. PubMed ID: 1738093
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of gentamicin-induced nephrotoxicity by pyridoxal-5'-phosphate in the rat.
Kacew S
J Pharmacol Exp Ther; 1989 Jan; 248(1):360-6. PubMed ID: 2492342
[TBL] [Abstract][Full Text] [Related]
10. Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats.
Giuliano RA; Paulus GJ; Verpooten GA; Pattyn VM; Pollet DE; Nouwen EJ; Laurent G; Carlier MB; Maldague P; Tulkens PM
Kidney Int; 1984 Dec; 26(6):838-47. PubMed ID: 6533395
[TBL] [Abstract][Full Text] [Related]
11. Reduction of gentamicin nephrotoxicity by the concomitant administration of poly-l-aspartic acid and poly-l-asparagine in rats.
Beauchamp D; Laurent G; Maldague P; Tulkens PM
Arch Toxicol Suppl; 1986; 9():306-9. PubMed ID: 3468909
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of gentamicin-induced nephrotoxicity by lithium in rat.
Samadian T; Dehpour AR; Amini S; Nouhnejad P
Histol Histopathol; 1993 Jan; 8(1):139-47. PubMed ID: 8443425
[TBL] [Abstract][Full Text] [Related]
13. Gentamicin or chlorphentermine induction of phospholipidosis in the developing organism: role of tissue and species in manifestation of toxicity.
Kacew S
J Pharmacol Exp Ther; 1985 Jan; 232(1):239-43. PubMed ID: 3965695
[TBL] [Abstract][Full Text] [Related]
14. Renal histological and biochemical changes induced in the rat by dibekacin.
Viotte G; Olier B; Morin JP; Fillastre JP
J Pharmacol Exp Ther; 1983 Jul; 226(1):226-31. PubMed ID: 6864541
[TBL] [Abstract][Full Text] [Related]
15. Tissue repair in rat kidney cortex after short treatment with aminoglycosides at low doses. A comparative biochemical and morphometric study.
Toubeau G; Laurent G; Carlier MB; Abid S; Maldague P; Heuson-Stiennon JA; Tulkens PM
Lab Invest; 1986 Apr; 54(4):385-93. PubMed ID: 3959542
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of gentamicin nephrotoxicity in rats and the protective effect of zinc-induced metallothionein synthesis.
Du XH; Yang CL
Nephrol Dial Transplant; 1994; 9 Suppl 4():135-40. PubMed ID: 7800247
[TBL] [Abstract][Full Text] [Related]
17. Poly-L-aspartic acid does but triiodothyronine does not protect against gentamicin-induced cytotoxicity in the porcine kidney cell line LLC-PK1.
Whittem T; Schnellmann RG; Ferguson DC
J Pharmacol Exp Ther; 1992 Aug; 262(2):834-40. PubMed ID: 1354256
[TBL] [Abstract][Full Text] [Related]
18. Effect of netilmicin on the phospholipid composition of subcellular fractions of rat renal cortex.
Josepovitz C; Farruggella T; Levine R; Lane B; Kaloyanides GJ
J Pharmacol Exp Ther; 1985 Dec; 235(3):810-9. PubMed ID: 3001278
[TBL] [Abstract][Full Text] [Related]
19. Gentamicin nephrotoxicity in rats. I. Acute biochemical and ultrastructural effects.
Vera-Roman J; Krishnakantha TP; Cuppage FE
Lab Invest; 1975 Oct; 33(4):412-7. PubMed ID: 1186122
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of renal membrane binding and nephrotoxicity of aminoglycosides.
Williams PD; Hottendorf GH; Bennett DB
J Pharmacol Exp Ther; 1986 Jun; 237(3):919-25. PubMed ID: 3754895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
